Establishment of a convenient and useful criteria based on clinicopathologic information that can easily determine the outcome of patients with gastric carcinoma could provide beneficial information for both the patients and the physicians.
INTRODUCTION
Establishment of a convenient and useful criteria based on clinicopathologic information that can easily determine the outcome of patients with gastric carcinoma could provide beneficial information for both the patients and the physicians.
Lymph node metastasis can be a representative parameter among the pathologic factors that predict tumor recurrence and the prognosis of patients with malignant tumors, including gastric carcinoma (1 -3) .
On the other hand, elevation of serum C-reactive protein, as part of the inflammatory response against the tumor, has been reported to be a useful predictor of the malignant potential of gastrointestinal tumors, including gastric carcinoma (4, 5) .
However, progression and invasion of human malignant tumors can be influenced by the balance between the environmental conditions around the tumors and the physical state of the tumorbearing patients.
In the current study, we developed a cumulative score, based on both the incidence of pathologic lymph node metastasis and preoperative elevation of serum CRP, and investigated whether it could provide a strict stratification of the prognosis of patients with gastric carcinoma who had been treated with curative resection.
PATIENTS AND METHODS

Patients, collection of blood samples, and measurement of C-reactive protein (CRP).
Three hundred and twenty patients with gastric carcinoma, comprised of 222 men and 98 women who had been treated by curative resection, defined as a standard distal or total gastrectomy with a D1+ or D2 lymph node dissection, in our institute between 1998 and 2012, were enrolled in this study.
Patients who had a history of malignant tumors in other organs or had other chronic inflammatory diseases that could lead to elevation of serum CRP were excluded.
No neoadjuvant therapy was administered to the patients enrolled in this study.
All blood samples for serum CRP measurements were collected just before the surgical procedure. Normal value of CRP was 1.0 mg/dL and then, patients who had serum CRP concentrations "1.0 mg/dL were regarded as CRP positive.
This study was approved by the institutional ethic committee of Fukuoka Higashi Medical Center.
Pathologic investigations. Pathologic factors were determined according to the TNM classification of malignant tumours prescribed by the International Union Against Cancer (6) .
Definition of the cumulative score. Patients who had both elevated serum CRP and pathologic lymph node metastasis were allocated a Score of 2 and patients who had only one or neither were allocated Scores of 1 or 0, respectively. Follow-up of the patients. The patients were followed-up until their death and only patients who died of gastric carcinoma were included in the tumor-related deaths. The period from the operation to the date of death was defined as the survival time. The follow-up interval after the operation ranged from 2 months to 9 years and 2 months.
Statistical analysis. All statistical analyses were performed using StatView (SAS Institute Inc, Cary, NC). Chi-square test and t test were used to compare the differences between values in each score group. Survival curves were constructed using the Kaplan-Meier method, and the Mantel -Cox test was used to analyze the equality of the survival curves. Cox proportional hazards model in a forward stepwise manner was used in the multivariate analysis to determine the independent prognostic indicators. P values ! 0.05 were considered significant.
RESULTS
The correlations between the cumulative score and the clinicopathologic characteristics are shown in Table I . Significant differences were observed regarding the location of the tumor (P = 0.021), depth of the tumor (P ! 0.0001), histological type (P = 0.0007), lymphatic invasion (P ! 0.0001), venous invasion (P ! 0.0001), stage of the tumors (P !0.0001), and the surgical resection procedure (P !0.0001). Additionally, a significant correlation of the cumulative score with carcinoembryonic antigen (CEA ; Table ! ! , P = 0.004) and with carbohydrate antigen 19 -9 (CA19 -9 ; Table ! ! ! , P !0.0001) was observed. The 1 -, 3 -and 5 -year survival rates of patients with a score of 0 were 100%, 100%, and 94.0%, respectively. These survival rates were 90.1%, 75.8%, and 69.1%, respectively, among patients with a score of 1, and 78.3%, 40.0% and 26.6%, respectively, among patients with a score of 2. Significant differences were observed between the survival of patients with scores of 0 and 1 (P ! 0.0001) and also between those with scores of 1 and 2 (P !0.0001, Figure. Values in the parenthesis are the percentages Fig. 1 . Survival curves among whole patients.
Significant differences were observed between the survival of patients with cumulative scores of 0 and 1 (P !0.0001) and those patients with cumulative scores of 1 and 2 (P !0.0001).
Analysis restricted to patients with stage ! !or ! ! !are shown in Table ! " . Significant differences were observed regarding the depth of the tumor (P = 0.038), lymphatic invasion (P ! 0.0001), stage of the tumors (P ! 0.0001), and the surgical resection procedure (P = 0.013). Similarly, significant differences were observed between the survival of patients with scores of 0 (with 5 -year survival rate of 88.9%) and 1 (with 5 -year survival rate of 61.4% ; P = 0.010) and also between those with scores of 1 and 2 (with 5 -year survival rate of 61.4% ; P = 0.0004, Figure. 2).
Multivariate analysis demonstrated that the cumulative score (P = 0.0003) and the depth of the tumor (P = 0.016) were independent prognostic indicators ( Table " ) .
DISCUSSION
The most difficult and serious problem in the clinical treatment of gastric carcinoma is that the subsequent outcome of the patients could be desperate in cases of distant metastasis with detection of the tumor and the tumor recurrence. While recurrent liver or lung tumors derived from colorectal carcinoma are occasionally indicated for surgical treatment followed by the systemic chemotherapy under some restricted conditions, recurrent tumors metastasized from gastric carcinoma are rarely subjected to surgical treatment due to its small contribution to the prolongation of the survival (7, 8) .
Therefore, in order to improve the prognosis of patients with gastric carcinoma, more useful and convenient information to predict tumor recurrence and the prognosis of patients with gastric carcinoma who have been treated with curative resection are necessary.
In establishing more useful prognostic criteria to predict the outcome of tumor -bearing disease that are both convenient and costeffective, laboratory and histological examinations might be used for patients with malignant tumors. While all of the pathological factors, including lymphatic permeation, venous invasion and lymph node metastasis, are indicators that can predict the aggressiveness of Significant differences were observed between the survival of patients with cumulative scores of 0 and 1 (P = 0.0010) and those patients with cumulative scores of 1 and 2 (P = 0.0004). (3, 9) and/or proportion (2) of the nodes involved by the carcinoma cells, could be a representative indicator for the biological potential of the tumors among these pathologic elements.
As a prognostic indicator based on laboratory data, elevation of serum C-reactive protein (CRP) has come to be used as an indicator of patient outcome in some human malignant tumors of the digestive tracts, including gastric carcinoma, both independently 5 and by such combined forms as the Glasgow Prognostic Score (GPS) (4, 10) .
While the scope of these investigations might suggest that criteria to determine patients' prognosis in gastric carcinoma based upon the combination of pathologic lymph node metastasis, as a representative of tumor-related factors, and elevation of serum CRP. as a representative of the host-related factors, appears to be much more useful, there has been no previous attempt to produce such criteria for patients with gastric cancer who had been treated with curative resection. Indeed, such attempts to readily reconstruct the criteria to determine and predict the prognosis of patients, based on both tumor-related and host related factors, have been introduced regarding colorectal carcinoma (11, 12) .
Indeed, in the current study, the cumulative score system formed by the combination of the presence of pathologic lymph node metastasis and elevation of serum CRP could provide a strict stratification of survival of patients with gastric carcinoma who have been treated with curative resection. And a similar results could be demonstrated in analysis restricted to patients with TNM stage ! ! or ! ! !tumors. Moreover, this cumulative score proved to be significant as an independent prognostic indicator of gastric carcinoma.
It holds true that the most popular criteria to determine prognosis in gastric cancer remains to be TNM staging system. However, our score system can be composed of two factors and simply classified to only three groups and the prognosis of the group could be clearly divided with a strict stratification, being the most outstanding advantage of our score system. And the most outstanding significance in this study is to create staging system based on both tumor-related and host-relates factors.
While determination of an existence of nodal metastasis might be found by diagnostic images including computed tomography (CT) and positron emission tomography (PET), our cumulative score system would exert an ability also to preoperatively predict the subsequent prognosis of the patients.
In conclusion, the cumulative score system generated by the basic data of pathologic nodal metastasis and elevation of serum CRP can be applied to the majority of the medical institutes and it could be an easy and useful information to predict outcome of the patients with gastric carcinoma that had been treated with curative surgical treatment.
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